The FDA has even accredited a drug designed with cannabidiol for that function (Epidiolex). But the company only recommends it for 2 unusual sorts of childhood epilepsy known as Lennox-Gastaut syndrome and Dravet syndrome.Using these solutions at a young age particularly boosts the probability of producing a cannabis use dysfunction later in everyd